BeStock  

Opko Health OPK

US equityMarket cap rank #3057Diagnostics & Research
$1.57 −$0.04 (-2.48%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.57 +0.04%
Open$1.57
Prev close$1.61
Day range$1.55 – $1.62
Volume3.52M
Market cap$1.17B
P/E (TTM)–
Dividend yield–

OPK Stock News

Headlines matching Opko Health or the OPK ticker, most recent first.

  • Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)TipRanks · 14 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3Market news · 14 Aug 2026 · Direct mention
  • Barrington Maintains Opko Health(OPK.US) With Hold RatingMarket news · 28 Jul 2026 · Direct mention
  • Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3Market news · 28 Jul 2026 · Direct mention
  • H.C. Wainwright Sticks to Their Buy Rating for Opko Health (OPK)TipRanks · 27 May 2026 · Direct mention
  • Barrington Downgrades Opko Health(OPK.US) to Hold Rating NegativeMarket news · 29 Apr 2026 · Direct mention
  • H.C. Wainwright Reaffirms Their Buy Rating on Opko Health (OPK)TipRanks · 2 Mar 2026 · Direct mention
  • Barrington Maintains Opko Health(OPK.US) With Buy Rating, Cuts Target Price to $1.5 NegativeMarket news · 2 Mar 2026 · Direct mention
  • Earnings Flash (OPK) OPKO Health, Inc. Reports Q3 Revenue $65.4M, Vs. FactSet Est of $136.6MMT Newswires · 5 Nov 2026 · Direct mention
  • Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $4Market news · 5 Nov 2026 · Direct mention
  • GUIDANCE: (OPK) OPKO Health, Inc. Expects Q4 Revenue Range $62.0M - $72.0MMT Newswires · 5 Nov 2026 · Direct mention
  • H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3Market news · 5 Nov 2026 · Direct mention
  • H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3Market news · 28 Oct 2026 · Direct mention
  • Barrington Upgrades Opko Health(OPK.US) to Buy Rating, Announces Target Price $2.25 PositiveMarket news · 17 Oct 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Opko Health (OPK) and Adlai Nortye Ltd. Sponsored ADR (ANL)TipRanks · 16 Oct 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on OPK.

Sign in to join the discussion.

Scroll to Top